Total Valuation
Phibro Animal Health has a market cap or net worth of €1.32B. The enterprise value is €1.99K.
Market Cap€1.32B
Enterprise Value€1.99K
Share Statistics
Phibro Animal Health has 21,105,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,105,570
Owned by Insiders1.18%
Owned by Institutions18.70%
Financial Efficiency
Phibro Animal Health’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 11.81%.
Return on Equity (ROE)0.26
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)11.81%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee582.76K
Profits Per Employee0.00
Employee Count2,605
Asset Turnover1.01
Inventory Turnover1.88
Valuation Ratios
The current PE Ratio of Phibro Animal Health is 15.3. Phibro Animal Health’s PEG ratio is 0.12.
PE Ratio15.3
PS Ratio0.84
PB Ratio3.31
Price to Fair Value3.31
Price to FCF129.22
Price to Operating Cash Flow22.18
PEG Ratio0.12
Income Statement
In the last 12 months, Phibro Animal Health had revenue of 1.52B and earned 99.72M in profits. Earnings per share was 2.46.
Revenue1.52B
Gross Profit511.71M
Operating Income198.44M
Pretax Income137.35M
Net Income99.72M
EBITDA236.46M
Earnings Per Share (EPS)2.46
Cash Flow
In the last 12 months, operating cash flow was 68.95M and capital expenditures -59.09M, giving a free cash flow of 9.87M billion.
Operating Cash Flow68.95M
Free Cash Flow9.87M
Free Cash Flow per Share0.47
Dividends & Yields
Phibro Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.73
52-Week Price Change0.60%
50-Day Moving Average29.24
200-Day Moving Average35.46
Relative Strength Index (RSI)54.89
Average Volume (3m)0.00
Important Dates
Phibro Animal Health upcoming earnings date is Nov 11, 2026, After Close (Confirmed).
Last Earnings DateAug 26, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Phibro Animal Health as a current ratio of 2.96, with Debt / Equity ratio of 204.62%
Current Ratio2.96
Quick Ratio1.27
Debt to Market Cap0.57
Net Debt to EBITDA3.08
Interest Coverage Ratio4.17
Taxes
In the past 12 months, Phibro Animal Health has paid 37.63M in taxes.
Income Tax37.63M
Effective Tax Rate0.27
Enterprise Valuation
Phibro Animal Health EV to EBITDA ratio is 8.47, with an EV/FCF ratio of 202.94.
EV to Sales1.32
EV to EBITDA8.47
EV to Free Cash Flow202.94
EV to Operating Cash Flow29.04
Balance Sheet
Phibro Animal Health has €81.99M in cash and marketable securities with €788.77M in debt, giving a net cash position of -€706.77M billion.
Cash & Marketable Securities€81.99M
Total Debt€788.77M
Net Cash-€706.77M
Net Cash Per Share-€33.49
Tangible Book Value Per Share€7.28
Margins
Gross margin is 33.71%, with operating margin of 13.07%, and net profit margin of 6.57%.
Gross Margin33.71%
Operating Margin13.07%
Pretax Margin9.05%
Net Profit Margin6.57%
EBITDA Margin15.58%
EBIT Margin12.18%
Analyst Forecast
The average price target for Phibro Animal Health is €49.75, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€49.75
Price Target Upside63.66% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast9.24%
EPS Growth Forecast92.49%